AG00IKK8

81403-80-7 | N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide

Chemical structure of N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide, CAS 81403-80-7
AG00IKK8
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 81403-80-7
Catalog Number AG00IKK8(AGN-PC-0UJDSI)
Chemical Name N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide
EC Number 617-230-8
IUPAC Name N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide
InChI InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)
InChI Key WNMJYKCGWZFFKR-UHFFFAOYSA-N
MDL Number MFCD00865792
Molecular Formula C19H27N5O4
Molecular Weight 389.4488
NSC Number 760065
SMILES COC1=C(OC)C=C2C(N=C(N(CCCNC(C3OCCC3)=O)C)N=C2N)=C1
Synonyms
Alfetim, alfusozine, alfuzosin, alfuzosin hydrochloride, alphuzosine, Benestan, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide, Urion, UroXatral, Xatral, alfuzosin, 81403-80-7, Alfuzosina, Alfuzosine, Alfuzosinum, Alfuzosine [French], Alfuzosinum [Latin], Alfusosine, Alfuzosina [Spanish], Alfuzosin [INN:BAN], ALFLUZOCIN, SL 77499, HSDB 7290, SL 77-499, CHEMBL709, CHEBI:51141, WNMJYKCGWZFFKR-UHFFFAOYSA-N, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide, N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide, C19H27N5O4, N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide, alphuzosine, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide, Alfuzosin (INN), 2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, SMR000466340, Xatral (TN), SL-77499-10, Alfuzosin/, N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl), SR-01000759345, n-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide, ALFLUZOSIN, AC1L1CWF, Prestwick0_000322, Prestwick1_000322, Prestwick2_000322, Prestwick3_000322, Spectrum2_000505, Spectrum3_001063, Spectrum4_001208, Spectrum5_000817, SCHEMBL34477, BSPBio_000323, BSPBio_002646, KBioGR_001616, MLS000759449, MLS001424027, MLS006011887, SPECTRUM1505263, SPBio_000429, SPBio_002244, BPBio1_000357, GTPL7109, DTXSID6048549, KBio3_001866, HMS1922P11, HMS2051I10, HMS2093O06, HMS2235O22, HMS3369K03, HMS3393I10, Pharmakon1600-01505263, ACT03219, HY-B0192, ABP000595, BDBM50033110, BG0022, CCG-39585, MFCD00865792, NSC760065, STK643675, AKOS005574697, API0001406, CCG-100859, CS-2086, DB00346, MCULE-9094645643, NC00109, NSC-760065, VA10203, NCGC00095152-01, NCGC00095152-02, NCGC00095152-03, NCGC00095152-04, NCGC00095152-05, NCGC00095152-07, AN-36345, CC-23834, CPD000466340, K449, LS-70106, SAM001246638, SC-17006, SBI-0206735.P001, AB0014226, AB00514667, FT-0630891, D07124, AB00514667-07, AB00514667-09, AB00514667-10, AB00514667_11, AB00514667_12, (methyl)amino)propyl)tetrahydrofuran-2-carboxamide, 403A807, A840122, C-21524, L001317, SR-01000759345-4, BRD-A09056319-001-02-2, BRD-A09056319-001-05-5, BRD-A09056319-003-03-6, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)-methylamino]propyl]-2-oxolanecarboxamide, N-[3-[(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]oxolane-2-carboxamide, N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide, (+/-)-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide, 2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-, N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide, N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide, N-[3-[(4-Amino-6,7-dimethoxy-quinazolin-2-yl)methylamino]propyl]tetrahydrofuran-2-carboxamide, N-{3-[(4-imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboximidic acid, Uroxatral, Xatral, Alfuzosin HCl, Alfuzosin Hydrochloride, Uroxatral (TN), D09MWJ, UNII-90347YTW5F, CID2092, 90347YTW5F, SL 77, C19-H27-N5-O4, CS-O-05655, 1683B, SL-7749910, 81403-68-1, N1-(4-amino-6,7-dimethoxyquinazol-2-yl)-N1-methyl-N2-(tetrahydrofuroyl-2)-propylenediamine,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited